Advertise
Resources
Member, Beacon International Group, Ltd.
Beneficiaries with end-stage renal disease are increasingly shifting from Medicare fee-for-service to Medicare Advantage, leading more Medicare Advantage plans to form value-based arrangements with kidney care management companies, finds an analysis by Avalere Health, Healthpayer Intelligence reports. A provision under the 21st Century Cures Act that went into effect on January 1, 2021, made all Medicare beneficiaries with ESRD eligible to enroll in Medicare Advantage plans.